View Filing Data

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2017	Apr. 28, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	Roper Technologies Inc
Entity Central Index Key	0000882835
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		102,031,970
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q1
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2017

Condensed Consolidated Statements of Earnings (unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Condensed Consolidated Statements of Earnings (unaudited) [Abstract]
Net sales	$ 1,086,305	$ 902,423
Cost of sales	418,691	342,904
Gross profit	667,614	559,519
Selling, general and administrative expenses	409,358	314,528
Income from operations	258,256	244,991
Interest expense, net	45,865	27,413
Other expense, net	(1,047)	(129)
Earnings before income taxes	211,344	217,449
Income taxes	53,273	66,033
Net earnings	$ 158,071	$ 151,416
Earnings per share:
Basic (in dollars per share)	$ 1.55	$ 1.50
Diluted (in dollars per share)	$ 1.53	$ 1.48
Weighted average common shares outstanding:
Basic (in shares)	101,885	101,071
Diluted (in shares)	103,078	102,318
Dividends declared per common share (in dollars per share)	$ 0.35	$ 0.30

Condensed Consolidated Statements of Comprehensive Income (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Condensed Consolidated Statements of Comprehensive Income (unaudited) [Abstract]
Net earnings	$ 158,071	$ 151,416
Other comprehensive income, net of tax:
Foreign currency translation adjustments	30,412	1,743
Total other comprehensive income, net of tax	30,412	1,743
Comprehensive income	$ 188,483	$ 153,159

Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
ASSETS:
Cash and cash equivalents	$ 730,666	$ 757,200
Accounts receivable, net	549,838	619,854
Inventories, net	191,426	181,952
Unbilled receivables	143,589	129,965
Prepaid income taxes	28,100	31,679
Other current assets	69,004	55,851
Total current assets	1,712,623	1,776,501
Property, plant and equipment, net	144,113	141,318
Goodwill	8,681,114	8,647,142
Other intangible assets, net	3,587,838	3,655,843
Deferred taxes	30,300	30,620
Other assets	74,066	73,503
Total assets	14,230,054	14,324,927
LIABILITIES AND STOCKHOLDERS' EQUITY:
Accounts payable	152,638	152,067
Accrued compensation	131,584	161,730
Deferred revenue	513,820	488,399
Other accrued liabilities	251,298	219,339
Income taxes payable	88,126	22,762
Current portion of long-term debt, net	401,072	400,975
Total current liabilities	1,538,538	1,445,272
Long-term debt, net of current portion	5,439,700	5,808,561
Deferred taxes	1,169,151	1,178,205
Other liabilities	111,875	104,024
Total liabilities	8,259,264	8,536,062
Commitments and contingencies (Note 8)
Common stock	1,039	1,036
Additional paid-in capital	1,518,213	1,489,067
Retained earnings	4,764,711	4,642,402
Accumulated other comprehensive earnings	(294,327)	(324,739)
Treasury stock	(18,846)	(18,901)
Total stockholders' equity	5,970,790	5,788,865
Total liabilities and stockholders' equity	$ 14,230,054	$ 14,324,927

Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities:
Net earnings	$ 158,071	$ 151,416
Adjustments to reconcile net earnings to cash flows from operating activities:
Depreciation and amortization of property, plant and equipment	12,377	9,702
Amortization of intangible assets	72,998	49,549
Amortization of deferred financing costs	1,821	1,359
Non-cash stock compensation	21,049	18,979
Changes in operating assets and liabilities, net of acquired businesses:
Accounts receivable	73,056	(16,355)
Unbilled receivables	(13,520)	2,296
Inventories	(7,905)	(3,907)
Accounts payable and accrued liabilities	(2,223)	(20,023)
Deferred revenues	34,308	292
Income taxes payable	39,013	20,127
Other, net	(10,828)	(6,363)
Cash provided by operating activities	378,217	207,072
Cash flows from investing activities:
Acquisitions of businesses, net of cash acquired	(2,829)	(265,248)
Capital expenditures	(14,930)	(9,489)
Capitalized software expenditures	(3,169)	(665)
Proceeds from sale of assets	109	673
Other, net	(500)	773
Cash used in investing activities	(21,319)	(273,956)
Cash flows from financing activities:
Payments under revolving line of credit, net	(370,000)	(160,000)
Principal payments on convertible notes	0	(289)
Cash premiums paid on convertible note conversions	0	(915)
Cash dividends to stockholders	(35,443)	(30,173)
Proceeds from stock based compensation, net	7,576	690
Treasury stock sales	1,032	879
Other	(250)	(374)
Cash used in financing activities	(397,085)	(190,182)
Effect of foreign currency exchange rate changes on cash	13,653	1,588
Net decrease in cash and cash equivalents	(26,534)	(255,478)
Cash and cash equivalents, beginning of period	757,200	778,511
Cash and cash equivalents, end of period	$ 730,666	$ 523,033

Condensed Consolidated Statement of Changes in Stockholders' Equity (unaudited) - 3 months ended Mar. 31, 2017 - USD ($) $ in Thousands	Common stock [Member]	Additional paid-in capital [Member]	Retained earnings [Member]	Accumulated other comprehensive earnings [Member]	Treasury stock [Member]	Total
Balances at at Dec. 31, 2016	$ 1,036	$ 1,489,067	$ 4,642,402	$ (324,739)	$ (18,901)	$ 5,788,865
Net earnings	0	0	158,071	0	0	158,071
Stock option exercises	1	12,932	0	0	0	12,933
Treasury stock sold	0	977	0	0	55	1,032
Currency translation adjustments, net of tax	0	0	0	30,412	0	30,412
Stock based compensation	0	20,598	0	0	0	20,598
Restricted stock activity	2	(5,361)	0	0	0	(5,359)
Dividends declared	0	0	(35,762)	0	0	(35,762)
Balances at at Mar. 31, 2017	$ 1,039	$ 1,518,213	$ 4,764,711	$ (294,327)	$ (18,846)	$ 5,970,790

Condensed Consolidated Statement of Changes in Stockholders' Equity (unaudited) (Parenthetical) $ in Thousands	3 Months Ended
	Mar. 31, 2017 USD ($)
Condensed Consolidated Statement of Changes in Stockholders' Equity (unaudited) [Abstract]
Currency translation adjustments, tax	$ 1,048

Basis of Presentation

3 Months Ended

Mar. 31, 2017

Basis of Presentation [Abstract]

Basis of Presentation

1.	Basis of Presentation

The accompanying condensed consolidated financial statements for the three months ended March 31, 2017 and 2016 are unaudited. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments, necessary to state fairly the financial position, results of operations, comprehensive income and cash flows of Roper Technologies, Inc. and its subsidiaries ("Roper" or the "Company") for all periods presented. The December 31, 2016 financial position data included herein was derived from the audited consolidated financial statements included in the 2016 Annual Report on Form 10-K ("Annual Report") filed on February 27, 2017 with the Securities and Exchange Commission ("SEC") but does not include all disclosures required by U.S. generally accepted accounting principles ("GAAP").

Roper's management has made estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities to prepare these condensed consolidated financial statements in conformity with GAAP. Actual results could differ from those estimates.

The results of operations for the three months ended March 31, 2017 are not necessarily indicative of the results to be expected for the full year. You should read these unaudited condensed consolidated financial statements in conjunction with Roper's audited consolidated financial statements and the notes thereto included in its Annual Report.

Recent Accounting Pronouncements

3 Months Ended

Mar. 31, 2017

Recent Accounting Pronouncements [Abstract]

Recent Accounting Pronouncement

2.	Recent Accounting Pronouncements

The Financial Accounting Standards Board ("FASB") establishes changes to accounting principles under GAAP in the form of accounting standards updates ("ASUs") to the FASB's Accounting Standards Codification. The Company considers the applicability and impact of all ASUs. Any recent ASUs not listed below were assessed and determined to be either not applicable or are expected to have an immaterial impact on the Company's results of operations, financial position or cash flows.

Recently Adopted Accounting Pronouncements

In July 2015, the FASB issued an update providing guidance to simplify the measurement of inventory. This update, effective for fiscal years beginning after December 15, 2016, requires that inventory within the scope of the update be measured at the lower of cost and net realizable value. The update did not have a material impact on the Company's results of operations, financial condition or cash flows.

Recently Released Accounting Pronouncements

In January 2017, the FASB issued an update simplifying the test for goodwill impairment. This update, effective on a prospective basis for annual or interim goodwill impairment tests performed in fiscal years beginning after December 15, 2019, eliminates Step 2 from the goodwill impairment test. Under the amendments in the update, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit's fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Additionally, an entity should consider income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The Company does not expect the update to have a material impact on its results of operations, financial condition or cash flows.

In August 2016, the FASB issued an update clarifying the classification of certain cash receipts and cash payments in the statement of cash flows. This update, effective for annual reporting periods after December 15, 2017, including interim periods within those annual periods, addresses the following eight specific cash flow issues: Debt prepayment or debt extinguishment costs; settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; contingent consideration payments made after a business combination; proceeds from the settlement of insurance claims; proceeds from the settlement of corporate-owned life insurance policies (including bank-owned life insurance policies); distributions received from equity method investees; beneficial interests in securitization transactions; and separately identifiable cash flows and application of the predominance principle. The Company does not expect the update to have a material impact on its results of operations, financial condition or cash flows.

In February 2016, the FASB issued an update on lease accounting. The update, effective for annual reporting periods after December 15, 2018, including interim periods within those annual periods, provides amendments to current lease accounting. These amendments include the recognition of lease assets and lease liabilities on the balance sheet and disclosing other key information about leasing arrangements. The Company is evaluating the impact of the update on its results of operations, financial condition and cash flows.

In May 2014, the FASB issued updates on accounting and disclosures for revenue from contracts with customers. These updates, effective for annual reporting periods after December 15, 2017, create a single, comprehensive revenue recognition model for all contracts with customers. The model is based on changes in contract assets (rights to receive consideration) and liabilities (obligations to provide a good or service). Revenue will be recognized based on the satisfaction of performance obligations, which occurs when control of a good or service transfers to a customer and enhanced disclosures will be required regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from an entity's contracts with customers. Either a retrospective or cumulative effect transition method is permitted; the Company has elected to adopt the modified retrospective transition method.

The Company has substantially completed its assessment to identify differences between the existing standard and new standard on its customer contracts. The Company is in the process of quantifying the estimated impact of these identified differences on its consolidated financial statements but does not believe the adoption will have material impact on its results of operations, financial condition or cash flows. The FASB has issued, and may issue in the future, interpretive guidance which may cause the evaluation to change. The Company believes it is following an appropriate timeline to allow for proper recognition, presentation and disclosure upon adoption effective the beginning of fiscal year 2018.

Earnings Per Share

3 Months Ended

Mar. 31, 2017

Earnings Per Share [Abstract]

Earnings Per Share

3.	Earnings Per Share

Basic earnings per share were calculated using net earnings and the weighted average number of shares of common stock outstanding during the respective period. Diluted earnings per share were calculated using net earnings and the weighted average number of shares of common stock and potential common stock outstanding during the respective period. Potentially dilutive common stock consisted of stock options and the premium over the conversion price on Roper's senior subordinated convertible notes based upon the trading price of Roper's common stock. The effects of potential common stock were determined using the treasury stock method. Weighted average shares outstanding are shown below (in thousands):

	Three months ended
	March 31,
	2017		2016
Basic shares outstanding		101,885		101,071
Effect of potential common stock:
Common stock awards		1,193		1,172
Senior subordinated convertible notes		-		75
Diluted shares outstanding		103,078		102,318

For the three months ended March 31, 2017, there were 661,525 outstanding stock options that were not included in the determination of diluted earnings per share because doing so would have been antidilutive, as compared to 988,475 outstanding stock options that would have been antidilutive for the three months ended March 31, 2016.

Stock Based Compensation

3 Months Ended

Mar. 31, 2017

Stock Based Compensation [Abstract]

Stock-Based Compensation

4.	Stock Based Compensation

The Roper Technologies, Inc. 2016 Incentive Plan ("2016 Plan") is a stock-based compensation plan used to grant incentive stock options, nonqualified stock options, restricted stock, stock appreciation rights or equivalent instruments to Roper's employees, officers and directors. The 2016 Plan replaces the Roper Technologies, Inc. Amended and Restated 2006 Incentive Plan ("2006 Plan"), and no additional grants will be made from the 2006 Plan.

Roper's stock purchase plan allows employees in the U.S. and Canada to designate up to 10% of eligible earnings to purchase Roper's common stock at a 5% discount to the average closing price of the stock at the beginning and end of a quarterly offering period. Common stock sold to employees may be either treasury stock, stock purchased on the open market, or newly issued shares.

The following table provides information regarding the Company's stock-based compensation expense (in thousands):

	Three months ended March 31,
	2017			2016
Stock based compensation		$	21,049		$	18,979
Tax effect recognized in net income			7,367			6,643

Stock Options - In the three months ended March 31, 2017, 452,400 options were granted with a weighted average fair value of $40.17 per option. During the same period in 2016, 547,125 options were granted with a weighted average fair value of $34.44 per option. All options were issued at grant date fair value, which is defined by both the 2016 Plan and the 2006 Plan as the closing price of Roper's common stock on the date of grant.

Roper records compensation expense for employee stock options based on the estimated fair value of the options on the date of grant using the Black-Scholes option-pricing model. Historical data is used to estimate the expected price volatility, the expected dividend yield, the expected option life and the expected forfeiture rate. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the estimated life of the option. The following weighted average assumptions were used to estimate the fair value of options granted during current and prior year periods using the Black-Scholes option-pricing model:

	Three months ended March 31,
	2017		2016
Risk-free interest rate (%)		2.09		1.41
Expected option life (years)		5.27		5.20
Expected volatility (%)		18.87		21.63
Expected dividend yield (%)		0.69		0.70

Cash received from option exercises for the three months ended March 31, 2017, and 2016 was $12.9 million and $1.9 million, respectively.

Restricted Stock Awards - During the three months ended March 31, 2017, 249,085 restricted stock awards were granted with a weighted average grant date fair value of $188.22 per restricted share. During the same period in 2016, 315,000 restricted stock awards were granted with a weighted average grant date fair value of $167.11 per restricted share. All grants were issued at grant date fair value.

During the three months ended March 31, 2017, 88,400 restricted awards vested with a weighted average grant date fair value of $145.68 per restricted share, and a weighted average vest date fair value of $206.92 per restricted share.

Employee Stock Purchase Plan - During the three months ended March 31, 2017 and 2016, participants in the employee stock purchase plan purchased 5,551 and 5,007 shares, respectively, of Roper's common stock for total consideration of $1.03 million and $0.88 million, respectively. All shares were purchased from Roper's treasury shares.

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References + Details

Inventories

3 Months Ended

Mar. 31, 2017

Inventories [Abstract]

Inventories

5. Inventories

The components of inventory were as follows (in thousands):

	March 31,			December 31,
	2017			2016
Raw materials and supplies	$	119,711		$	113,632
Work in process		26,589			24,290
Finished products		82,848			81,263
Inventory reserves		(37,722	)		(37,233	)
	$	191,426		$	181,952

Goodwill and Other Intangible Assets

3 Months Ended

Mar. 31, 2017

Goodwill and Other Intangible Assets [Abstract]

Goodwill and Intangible Assets

6.	Goodwill and Other Intangible Assets

The carrying value of goodwill by segment was as follows (in thousands):

	Medical & Scientific Imaging		RF Technology		Industrial Technology		Energy Systems & Controls		Total
Balances at December 31, 2016	$	3,185,071	$	4,687,670	$	363,978	$	410,423	$	8,647,142
Other		3,556		19,574		-		-		23,130
Currency translation adjustments		3,225		2,903		3,090		1,624		10,842
Balances at March 31, 2017	$	3,191,852	$	4,710,147	$	367,068	$	412,047	$	8,681,114

Other relates primarily to tax purchase accounting, intangibles valuations and working capital adjustments for 2016 acquisitions.

Other intangible assets were comprised of (in thousands):

	Cost		Accumulated amortization			Net book value
Assets subject to amortization:
Customer related intangibles	$	3,272,081	$	(712,718	)	$	2,559,363
Unpatented technology		462,152		(144,025	)		318,127
Software		184,761		(56,882	)		127,879
Patents and other protective rights		24,656		(20,399	)		4,257
Trade names		6,591		(653	)		5,938
Assets not subject to amortization:
Trade names		578,279		-			578,279
In process research and development		62,000		-			62,000
Balances at December 31, 2016	$	4,590,520	$	(934,677	)	$	3,655,843
Assets subject to amortization:
Customer related intangibles	$	3,274,117	$	(764,054	)	$	2,510,063
Unpatented technology		463,399		(158,751	)		304,648
Software		184,846		(63,850	)		120,996
Patents and other protective rights		25,425		(20,625	)		4,800
Trade names		6,598		(920	)		5,678
Assets not subject to amortization:
Trade names		579,653		-			579,653
In process research and development		62,000		-			62,000
Balances at March 31, 2017	$	4,596,038	$	(1,008,200	)	$	3,587,838

Amortization expense of other intangible assets was $72,695 and $49,048 during the three months ended March 31, 2017 and 2016, respectively.

An evaluation of the carrying value of goodwill and indefinite-lived intangibles is required to be performed on an annual basis and on an interim basis if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. There have been no events or changes in circumstances which indicate an interim impairment review is required in 2017. The Company expects to perform the annual analysis during the fourth quarter.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details

Fair Value of Financial Instruments

3 Months Ended

Mar. 31, 2017

Fair Value of Financial Instruments [Abstract]

Fair Value of Financial Instruments

7.	Fair Value of Financial Instruments

Roper's debt at March 31, 2017 included $4.3 billion of fixed-rate senior notes with the following fair values (in millions):

$400 million 1.850% senior notes due 2017	$	401
$800 million 2.050% senior notes due 2018		803
$500 million 6.250% senior notes due 2019		547
$600 million 3.000% senior notes due 2020		611
$500 million 2.800% senior notes due 2021		500
$500 million 3.125% senior notes due 2022		504
$300 million 3.850% senior notes due 2025		304
$700 million 3.800% senior notes due 2026		703

The fair values of the senior notes are based on the trading prices of the notes, which the Company has determined to be Level 2 in the FASB fair value hierarchy.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Contingencies

3 Months Ended

Mar. 31, 2017

Contingencies [Abstract]

Contingencies

8.	Contingencies

Roper, in the ordinary course of business, is the subject of, or a party to, various pending or threatened legal actions, including product liability and employment practices that, in general, are based upon claims of the kind that have been customary over the past several years and which the Company is vigorously defending. After analyzing the Company's contingent liabilities on a gross basis and, based upon past experience with resolution of its product liability and employment practices claims and the limits of the primary, excess, and umbrella liability insurance coverages that are available with respect to pending claims, management believes that adequate provision has been made to cover any potential liability not covered by insurance, and that the ultimate liability, if any, arising from these actions should not have a material adverse effect on Roper's consolidated financial position, results of operations or cash flows.

Roper or its subsidiaries have been named defendants along with numerous industrial companies in asbestos-related litigation claims in certain U.S. states. No significant resources have been required by Roper to respond to these cases and Roper believes it has valid defenses to such claims and, if required, intends to defend them vigorously. Given the state of these claims it is not possible to determine the potential liability, if any.

Roper's consolidated financial statements include accruals for potential product liability and warranty claims based on its claims experience. Such costs are accrued at the time revenue is recognized. A summary of the warranty accrual activity for the three months ended March 31, 2017 is presented below (in thousands):

Balances at December 31, 2016	$	10,548
Additions charged to costs and expenses		3,967
Deductions		(4,046	)
Other		49
Balances at March 31, 2017	$	10,518

- Definition

The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14472-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6851643&loc=d3e12021-110248

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14394-108349

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14557-108349

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6851643&loc=d3e12053-110248

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14453-108349

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14615-108349

+ Details

Business Segments

3 Months Ended

Mar. 31, 2017

Segment and Geographic Area Information [Abstract]

Business Segments

9.	Business Segments

Sales and operating profit by industry segment are set forth in the following table (dollars in thousands):

	Three Months Ended March 31,
	2017		2016		Change
Net sales:
Medical & Scientific Imaging	$	348,235	$	332,214		4.8	%
RF Technology		429,619		280,210		53.3	%
Industrial Technology		183,404		171,235		7.1	%
Energy Systems & Controls		125,047		118,764		5.3	%
Total	$	1,086,305	$	902,423		20.4	%
Gross profit:
Medical & Scientific Imaging	$	251,930	$	246,897		2.0	%
RF Technology		251,478		160,365		56.8	%
Industrial Technology		93,151		86,020		8.3	%
Energy Systems & Controls		71,055		66,237		7.3	%
Total	$	667,614	$	559,519		19.3	%
Operating profit*:
Medical & Scientific Imaging	$	119,793	$	114,456		4.7	%
RF Technology		88,984		88,766		0.2	%
Industrial Technology		53,613		46,759		14.7	%
Energy Systems & Controls		30,236		24,182		25.0	%
Total	$	292,626	$	274,163		6.7	%
Long-lived assets:
Medical & Scientific Imaging	$	44,689	$	40,621		10.0	%
RF Technology		76,652		30,828		148.6	%
Industrial Technology		34,067		36,802		(7.4	)%
Energy Systems & Controls		9,550		12,071		(20.9	)%
Total	$	164,958	$	120,322		37.1	%

* Segment operating profit is before unallocated corporate general and administrative expenses of $34,370 and $29,172 for the three months ended March 31, 2017 and 2016, respectively.

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599

+ Details

Recent Accounting Pronouncements (Policies)

3 Months Ended

Mar. 31, 2017

Recent Accounting Pronouncements [Abstract]

New Accounting Pronouncements

2.	Recent Accounting Pronouncements

Recently Adopted Accounting Pronouncements

Recently Released Accounting Pronouncements

Earnings Per Share (Policies)	3 Months Ended
Earnings Per Share (Policies)	Mar. 31, 2017
Earnings Per Share [Abstract]
Earnings Per Share	Basic earnings per share were calculated using net earnings and the weighted average number of shares of common stock outstanding during the respective period. Diluted earnings per share were calculated using net earnings and the weighted average number of shares of common stock and potential common stock outstanding during the respective period. Potentially dilutive common stock consisted of stock options and the premium over the conversion price on Roper's senior subordinated convertible notes based upon the trading price of Roper's common stock. The effects of potential common stock were determined using the treasury stock method. Weighted average shares outstanding are shown below (in thousands):

Stock Based Compensation (Policies)	3 Months Ended
Stock Based Compensation (Policies)	Mar. 31, 2017
Stock Based Compensation [Abstract]
Stock Based Compensation	Roper records compensation expense for employee stock options based on the estimated fair value of the options on the date of grant using the Black-Scholes option-pricing model. Historical data is used to estimate the expected price volatility, the expected dividend yield, the expected option life and the expected forfeiture rate. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the estimated life of the option. The following weighted average assumptions were used to estimate the fair value of options granted during current and prior year periods using the Black-Scholes option-pricing model:

Earnings Per Share (Tables)

3 Months Ended

Mar. 31, 2017

Earnings Per Share [Abstract]

Weighted Average Shares Outstanding

	Three months ended
	March 31,
	2017		2016
Basic shares outstanding		101,885		101,071
Effect of potential common stock:
Common stock awards		1,193		1,172
Senior subordinated convertible notes		-		75
Diluted shares outstanding		103,078		102,318

Stock Based Compensation (Tables)

3 Months Ended

Mar. 31, 2017

Stock Based Compensation [Abstract]

Stock Based Compensation Expense

The following table provides information regarding the Company's stock-based compensation expense (in thousands):

	Three months ended March 31,
	2017			2016
Stock based compensation		$	21,049		$	18,979
Tax effect recognized in net income			7,367			6,643

Weighted Average Assumptions Used to Value Option Grants

	Three months ended March 31,
	2017		2016
Risk-free interest rate (%)		2.09		1.41
Expected option life (years)		5.27		5.20
Expected volatility (%)		18.87		21.63
Expected dividend yield (%)		0.69		0.70

Cash received from option exercises for the three months ended March 31, 2017, and 2016 was $12.9 million and $1.9 million, respectively.

Inventories (Tables)

3 Months Ended

Mar. 31, 2017

Inventories [Abstract]

Inventories

The components of inventory were as follows (in thousands):

	March 31,			December 31,
	2017			2016
Raw materials and supplies	$	119,711		$	113,632
Work in process		26,589			24,290
Finished products		82,848			81,263
Inventory reserves		(37,722	)		(37,233	)
	$	191,426		$	181,952

Goodwill and Other Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2017

Goodwill and Other Intangible Assets [Abstract]

Goodwill

The carrying value of goodwill by segment was as follows (in thousands):

	Medical & Scientific Imaging		RF Technology		Industrial Technology		Energy Systems & Controls		Total
Balances at December 31, 2016	$	3,185,071	$	4,687,670	$	363,978	$	410,423	$	8,647,142
Other		3,556		19,574		-		-		23,130
Currency translation adjustments		3,225		2,903		3,090		1,624		10,842
Balances at March 31, 2017	$	3,191,852	$	4,710,147	$	367,068	$	412,047	$	8,681,114

Other Intangible Assets

Other intangible assets were comprised of (in thousands):

	Cost		Accumulated amortization			Net book value
Assets subject to amortization:
Customer related intangibles	$	3,272,081	$	(712,718	)	$	2,559,363
Unpatented technology		462,152		(144,025	)		318,127
Software		184,761		(56,882	)		127,879
Patents and other protective rights		24,656		(20,399	)		4,257
Trade names		6,591		(653	)		5,938
Assets not subject to amortization:
Trade names		578,279		-			578,279
In process research and development		62,000		-			62,000
Balances at December 31, 2016	$	4,590,520	$	(934,677	)	$	3,655,843
Assets subject to amortization:
Customer related intangibles	$	3,274,117	$	(764,054	)	$	2,510,063
Unpatented technology		463,399		(158,751	)		304,648
Software		184,846		(63,850	)		120,996
Patents and other protective rights		25,425		(20,625	)		4,800
Trade names		6,598		(920	)		5,678
Assets not subject to amortization:
Trade names		579,653		-			579,653
In process research and development		62,000		-			62,000
Balances at March 31, 2017	$	4,596,038	$	(1,008,200	)	$	3,587,838

Fair Value of Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2017

Fair Value of Financial Instruments [Abstract]

Fixed-Rate Senior Notes, Fair Value

Roper's debt at March 31, 2017 included $4.3 billion of fixed-rate senior notes with the following fair values (in millions):

$400 million 1.850% senior notes due 2017	$	401
$800 million 2.050% senior notes due 2018		803
$500 million 6.250% senior notes due 2019		547
$600 million 3.000% senior notes due 2020		611
$500 million 2.800% senior notes due 2021		500
$500 million 3.125% senior notes due 2022		504
$300 million 3.850% senior notes due 2025		304
$700 million 3.800% senior notes due 2026		703

Contingencies (Tables)

3 Months Ended

Mar. 31, 2017

Contingencies [Abstract]

Warranty Accrual Activity

Balances at December 31, 2016	$	10,548
Additions charged to costs and expenses		3,967
Deductions		(4,046	)
Other		49
Balances at March 31, 2017	$	10,518

Business Segments (Tables)

3 Months Ended

Mar. 31, 2017

Segment and Geographic Area Information [Abstract]

Sales and Operating Profit by Business Segment

Sales and operating profit by industry segment are set forth in the following table (dollars in thousands):

	Three Months Ended March 31,
	2017		2016		Change
Net sales:
Medical & Scientific Imaging	$	348,235	$	332,214		4.8	%
RF Technology		429,619		280,210		53.3	%
Industrial Technology		183,404		171,235		7.1	%
Energy Systems & Controls		125,047		118,764		5.3	%
Total	$	1,086,305	$	902,423		20.4	%
Gross profit:
Medical & Scientific Imaging	$	251,930	$	246,897		2.0	%
RF Technology		251,478		160,365		56.8	%
Industrial Technology		93,151		86,020		8.3	%
Energy Systems & Controls		71,055		66,237		7.3	%
Total	$	667,614	$	559,519		19.3	%
Operating profit*:
Medical & Scientific Imaging	$	119,793	$	114,456		4.7	%
RF Technology		88,984		88,766		0.2	%
Industrial Technology		53,613		46,759		14.7	%
Energy Systems & Controls		30,236		24,182		25.0	%
Total	$	292,626	$	274,163		6.7	%
Long-lived assets:
Medical & Scientific Imaging	$	44,689	$	40,621		10.0	%
RF Technology		76,652		30,828		148.6	%
Industrial Technology		34,067		36,802		(7.4	)%
Energy Systems & Controls		9,550		12,071		(20.9	)%
Total	$	164,958	$	120,322		37.1	%

* Segment operating profit is before unallocated corporate general and administrative expenses of $34,370 and $29,172 for the three months ended March 31, 2017 and 2016, respectively.

Earnings Per Share (Details) - shares	3 Months Ended
Earnings Per Share (Details) - shares	Mar. 31, 2017	Mar. 31, 2016
Schedule of weighted average shares outstanding [Abstract]
Basic shares outstanding (in shares)	101,885,000	101,071,000
Effect of potential common stock [Abstract]
Common stock awards (in shares)	1,193,000	1,172,000
Senior subordinated convertible notes (in shares)	0	75,000
Diluted shares outstanding (in shares)	103,078,000	102,318,000
Stock Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive stock options (in shares)	661,525	988,475

Stock Based Compensation (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Stock Based Compensation Expense [Abstract]
Stock based compensation	$ 21,049	$ 18,979
Tax effect recognized in net income	$ 7,367	$ 6,643
Stock Options [Member]
Stock Based Compensation Expense [Abstract]
Employee stock options granted during the period (in shares)	452,400	547,125
Fair value per share (in dollars per share)	$ 40.17	$ 34.44
Weighted average assumptions used to value option grants [Abstract]
Risk-free interest rate	2.09%	1.41%
Expected option life	5 years 3 months 7 days	5 years 2 months 12 days
Expected volatility	18.87%	21.63%
Expected dividend yield	0.69%	0.70%
Cash received from exercise of options	$ 12,900	$ 1,900
Restricted Stock Awards [Member]
Weighted average assumptions used to value option grants [Abstract]
Restricted stock awards granted during period (in shares)	249,085	315,000
Weighted average fair value per share of restricted stock awards granted during the period (in dollars per share)	$ 188.22	$ 167.11
Restricted stock awards vested during period (in shares)	88,400
Weighted average grant date fair value per share (in dollars per share)	$ 145.68
Weighted average vest date fair value per share (in dollars per share)	$ 206.92
Employee Stock Purchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of eligible earnings to purchase common stock through the employee stock purchase plan	10.00%
Discount on the average closing price for the employee stock purchase plan	5.00%
Weighted average assumptions used to value option grants [Abstract]
Shares of stock purchased during the period by participants in the employee stock purchase plan (in shares)	5,551	5,007
Amount paid for stock purchased during the period by participants in the employee stock purchase plan	$ 1,030	$ 880

Inventories (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Inventories [Abstract]
Raw materials and supplies	$ 119,711	$ 113,632
Work in process	26,589	24,290
Finished products	82,848	81,263
Inventory reserves	(37,722)	(37,233)
Total Inventory	$ 191,426	$ 181,952

Goodwill and Other Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Goodwill [Line Items]
Balances	$ 8,647,142
Other	23,130
Currency translation adjustments	10,842
Balances	8,681,114
Finite-Lived Intangible Assets [Line Items]
Accumulated amortization	(1,008,200)		$ (934,677)
Intangible Assets - Cost and Net Book Value [Abstract]
Cost	4,596,038		4,590,520
Net book value	3,587,838		3,655,843
Amortization expense of other intangible assets	72,695	$ 49,048
Medical and Scientific Imaging [Member]
Goodwill [Line Items]
Balances	3,185,071
Other	3,556
Currency translation adjustments	3,225
Balances	3,191,852
RF Technology [Member]
Goodwill [Line Items]
Balances	4,687,670
Other	19,574
Currency translation adjustments	2,903
Balances	4,710,147
Industrial Technology [Member]
Goodwill [Line Items]
Balances	363,978
Other	0
Currency translation adjustments	3,090
Balances	367,068
Energy Systems and Controls [Member]
Goodwill [Line Items]
Balances	410,423
Other	0
Currency translation adjustments	1,624
Balances	412,047
Trade Names [Member]
Indefinite-lived Intangible Assets [Line Items]
Assets not subject to amortization	579,653		578,279
In Process Research and Development [Member]
Indefinite-lived Intangible Assets [Line Items]
Assets not subject to amortization	62,000		62,000
Customer Related Intangibles [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	3,274,117		3,272,081
Accumulated amortization	(764,054)		(712,718)
Net book value	2,510,063		2,559,363
Unpatented Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	463,399		462,152
Accumulated amortization	(158,751)		(144,025)
Net book value	304,648		318,127
Software [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	184,846		184,761
Accumulated amortization	(63,850)		(56,882)
Net book value	120,996		127,879
Patents and Other Protective Rights [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	25,425		24,656
Accumulated amortization	(20,625)		(20,399)
Net book value	4,800		4,257
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	6,598		6,591
Accumulated amortization	(920)		(653)
Net book value	$ 5,678		$ 5,938

Fair Value of Financial Instruments (Details) - Fair Value, Inputs, Level 2 [Member] $ in Millions	3 Months Ended
	Mar. 31, 2017 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed rate senior notes carrying amount	$ 4,300
Senior Notes due 2017 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Face value of debt	400
Senior notes due 2017 fair value	$ 401
Debt Instrument, Interest Rate	1.85%
Maturity date of debt	Nov. 15, 2017
Senior notes due 2018 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Face value of debt	$ 800
Senior notes due 2018 fair value	$ 803
Debt Instrument, Interest Rate	2.05%
Maturity date of debt	Oct. 01, 2018
Senior notes due 2019 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Face value of debt	$ 500
Senior notes due 2019 fair value	$ 547
Debt Instrument, Interest Rate	6.25%
Maturity date of debt	Sep. 01, 2019
Senior Notes due 2020 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Face value of debt	$ 600
Senior notes due 2020 fair value	$ 611
Debt Instrument, Interest Rate	3.00%
Maturity date of debt	Dec. 15, 2020
Senior Notes due 2021 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Face value of debt	$ 500
Senior notes due 2022 fair value	$ 500
Debt Instrument, Interest Rate	2.80%
Maturity date of debt	Dec. 15, 2021
Senior Notes due 2022 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Face value of debt	$ 500
Senior notes due 2025 fair value	$ 504
Debt Instrument, Interest Rate	3.125%
Maturity date of debt	Nov. 15, 2022
Senior Notes due 2025 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Face value of debt	$ 300
Senior notes due 2025 fair value	$ 304
Debt Instrument, Interest Rate	3.85%
Maturity date of debt	Dec. 15, 2025
Senior Notes due 2026 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Face value of debt	$ 700
Senior notes due 2025 fair value	$ 703
Debt Instrument, Interest Rate	3.80%
Maturity date of debt	Dec. 15, 2026

Contingencies (Details) $ in Thousands	3 Months Ended
Contingencies (Details) $ in Thousands	Mar. 31, 2017 USD ($)
Warranty Accrual Activity [Roll Forward]
Balance	$ 10,548
Additions charged to costs and expenses	3,967
Deductions	(4,046)
Other	49
Balance	$ 10,518

Business Segments (Details) - USD ($)
$ in Thousands

3 Months Ended

Mar. 31, 2017

Mar. 31, 2016

Segment Reporting Information [Line Items]

Net sales

$ 1,086,305

$ 902,423

Percent change in net sales

20.40%

Gross profit

$ 667,614

559,519

Percent change in gross profit

19.30%

Operating profit

^[1]

$ 292,626

274,163

Percent change in operating profit

^[1]

6.70%

Long-lived assets

$ 164,958

120,322

Percent change in long-lived assets

37.10%

Operating Segments [Member] | Medical and Scientific Imaging [Member]

Segment Reporting Information [Line Items]

Net sales

$ 348,235

332,214

Percent change in net sales

4.80%

Gross profit

$ 251,930

246,897

Percent change in gross profit

2.00%

Operating profit

^[1]

$ 119,793

114,456

Percent change in operating profit

^[1]

4.70%

Long-lived assets

$ 44,689

40,621

Percent change in long-lived assets

10.00%

Operating Segments [Member] | RF Technology [Member]

Segment Reporting Information [Line Items]

Net sales

$ 429,619

280,210

Percent change in net sales

53.30%

Gross profit

$ 251,478

160,365

Percent change in gross profit

56.80%

Operating profit

^[1]

$ 88,984

88,766

Percent change in operating profit

^[1]

0.20%

Long-lived assets

$ 76,652

30,828

Percent change in long-lived assets

148.60%

Operating Segments [Member] | Industrial Technology [Member]

Segment Reporting Information [Line Items]

Net sales

$ 183,404

171,235

Percent change in net sales

7.10%

Gross profit

$ 93,151

86,020

Percent change in gross profit

8.30%

Operating profit

^[1]

$ 53,613

46,759

Percent change in operating profit

^[1]

14.70%

Long-lived assets

$ 34,067

36,802

Percent change in long-lived assets

(7.40%)

Operating Segments [Member] | Energy Systems and Controls [Member]

Segment Reporting Information [Line Items]

Net sales

$ 125,047

118,764

Percent change in net sales

5.30%

Gross profit

$ 71,055

66,237

Percent change in gross profit

7.30%

Operating profit

^[1]

$ 30,236

24,182

Percent change in operating profit

^[1]

25.00%

Long-lived assets

$ 9,550

12,071

Percent change in long-lived assets

(20.90%)

Corporate [Member]

Segment Reporting Information [Line Items]

Unallocated corporate general and administrative expenses

^[1]

$ 34,370

$ 29,172

[1]	* Segment operating profit is before unallocated corporate general and administrative expenses of $34,370 and $29,172 for the three months ended March 31, 2017 and 2016, respectively.